The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study
Public ClinicalTrials.gov record NCT00407381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Ranibizumab for Edema of the Macula in Diabetes: a Phase 2 Study ( The Read-2 Study)
Study identification
- NCT ID
- NCT00407381
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Johns Hopkins University
- Other
- Enrollment
- 126 participants
Conditions and interventions
Conditions
Interventions
- Laser photocoagulation Procedure
- Ranibizumab Drug
Procedure · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2006
- Primary completion
- Jul 31, 2010
- Completion
- Jul 31, 2011
- Last update posted
- Mar 30, 2017
2006 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Consultants of Arizona | Phoenix | Arizona | 85014 | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills | California | 90211 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| East Bay Retina Consultants | Oakland | California | 94609 | — |
| Retina Institute of California | Pasadena | California | 91105 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Yale Eye Center | New Haven | Connecticut | 06511 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Illinois Retina Associates Rush University | Chicago | Illinois | 60435 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Midwest Eye Institute | Indianapolis | Indiana | 46280 | — |
| Wilmer Eye Institute at Johns Hopkins University School of Medicine | Baltimore | Maryland | 21287 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| New England Retina Consultants, PC | West Springfield | Massachusetts | 01089 | — |
| Retinal Consultants of Nevada | Las Vegas | Nevada | 89109 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131 | — |
| Duke Eye Center | Durham | North Carolina | 27710 | — |
| Eye Care Specialists, PC | Kingston | Pennsylvania | 18704 | — |
| Southern New England Retina Associates | Providence | Rhode Island | 02903 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00407381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2017 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00407381 live on ClinicalTrials.gov.